Skip to main content
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
editorial
. 1981 Feb 28;282(6265):676–677. doi: 10.1136/bmj.282.6265.676

Prevention of haemolytic diseases of the newborn due to anti-D.

PMCID: PMC1504501  PMID: 6781610

Full text

PDF
676

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. FINN R., CLARKE C. A., DONOHOE W. T., McCONNELL R. B., SHEPPARD P. M., LEHANE D., KULKE W. Experimental studies on the prevention of Rh haemolytic disease. Br Med J. 1961 May 27;1(5238):1486–1490. doi: 10.1136/bmj.1.5238.1486. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. FREDA V. J., GORMAN J. G. Antepartum management of Rh hemolytic disease. Bull Sloane Hosp Women Columbia Presbyt Med. 1962;8:147–158. [PubMed] [Google Scholar]
  3. McMaster conference on prevention of Rh immunization. 28-30 September, 1977. Vox Sang. 1979;36(1):50–64. [PubMed] [Google Scholar]
  4. Tovey G. H. Should anti-D immunoglobulin be given antenatally? Lancet. 1980 Aug 30;2(8192):466–468. doi: 10.1016/s0140-6736(80)91898-x. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES